What is HC Wainwright's Estimate for Liquidia Q1 Earnings?

Liquidia Co. (NASDAQ:LQDA - Free Report) - Stock analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Liquidia in a report issued on Thursday, March 20th. HC Wainwright analyst A. Fein anticipates that the company will post earnings per share of ($0.49) for the quarter. HC Wainwright has a "Buy" rating and a $29.00 price objective on the stock. The consensus estimate for Liquidia's current full-year earnings is ($1.51) per share. HC Wainwright also issued estimates for Liquidia's FY2025 earnings at ($1.53) EPS, FY2026 earnings at ($0.91) EPS, FY2027 earnings at ($0.47) EPS and FY2028 earnings at ($0.07) EPS.

Several other research analysts also recently weighed in on LQDA. Wells Fargo & Company started coverage on shares of Liquidia in a research note on Friday, December 20th. They issued an "overweight" rating and a $20.00 target price for the company. Needham & Company LLC boosted their price objective on shares of Liquidia from $19.00 to $25.00 and gave the company a "buy" rating in a research report on Thursday, March 20th. Finally, Scotiabank restated an "outperform" rating on shares of Liquidia in a research report on Thursday, March 20th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $26.63.

Liquidia Trading Up 2.5 %

Shares of NASDAQ:LQDA traded up $0.37 on Monday, hitting $15.24. The company had a trading volume of 525,027 shares, compared to its average volume of 930,226. The company has a market cap of $1.30 billion, a PE ratio of -9.35 and a beta of 0.07. Liquidia has a 52-week low of $8.26 and a 52-week high of $16.81. The business has a 50 day moving average of $15.01 and a 200 day moving average of $12.34.

Remove Ads

Liquidia (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings data on Wednesday, March 19th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.08). The company had revenue of $2.92 million for the quarter, compared to analyst estimates of $4.60 million. Liquidia had a negative return on equity of 163.21% and a negative net margin of 765.38%.

Insiders Place Their Bets

In related news, insider Rajeev Saggar sold 6,249 shares of Liquidia stock in a transaction dated Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total value of $73,613.22. Following the completion of the transaction, the insider now directly owns 270,388 shares in the company, valued at approximately $3,185,170.64. This trade represents a 2.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Michael Kaseta sold 23,370 shares of the stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total value of $275,298.60. Following the transaction, the chief financial officer now directly owns 401,755 shares in the company, valued at approximately $4,732,673.90. This represents a 5.50 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 71,245 shares of company stock worth $843,326 over the last three months. 30.10% of the stock is owned by insiders.

Institutional Investors Weigh In On Liquidia

Several institutional investors and hedge funds have recently made changes to their positions in LQDA. Vanguard Group Inc. boosted its holdings in Liquidia by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 3,557,296 shares of the company's stock worth $41,834,000 after purchasing an additional 115,367 shares during the period. LM Advisors LLC bought a new position in shares of Liquidia in the 4th quarter worth about $25,948,000. Whitefort Capital Management LP boosted its holdings in shares of Liquidia by 16.8% in the 4th quarter. Whitefort Capital Management LP now owns 1,987,245 shares of the company's stock valued at $23,370,000 after buying an additional 285,220 shares during the period. Vestal Point Capital LP raised its stake in Liquidia by 17.3% during the fourth quarter. Vestal Point Capital LP now owns 1,760,000 shares of the company's stock worth $20,698,000 after acquiring an additional 260,000 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Liquidia by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 1,339,254 shares of the company's stock worth $15,753,000 after acquiring an additional 101,597 shares during the last quarter. 64.54% of the stock is owned by institutional investors and hedge funds.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).